In-vitro evaluation of meloxicam permeation using response surface methodology

Journal of Food and Drug Analysis

Volumn 14, Issue 3, 2006, Pages 236-241

  Chang, Jui Sheng ^a   Wu, Pao Chu ^a   Huang, Yaw Bin ^a   Tsai, Yi Hung ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Azone; In vitro permeation; Meloxicam; Response surface methodology

Indexed keywords

DODECYL SULFATE SODIUM; HYDROXYPROPYLCELLULOSE; LAUROCAPRAM; MELOXICAM; MENTHOL; PIROXICAM;

ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG SCREENING; GEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; HYPOTHESIS; IN VITRO STUDY; MATHEMATICAL ANALYSIS; NONHUMAN; PREDICTION; PROCESS MODEL; RAT; RESPONSE SURFACE METHOD; SKIN PENETRATION; TIME;

EID: 33751369025     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Engerlhardt, G., 1996. Pharmacology of meloxicam, a new non-sterodial anti-inflammatory drug with an improved safety profile through preferential inhibition of cox-2. Br. J. Rheumatol. 35: 4-12.
2. Noble, S., Balfour, J.A., 1996. Meloxicam. Drugs, 51, 424-230.
3. Stei, P., Kruss, B., Wiegleb, J., Trach, V., 1996. Local tissue toterability of meloxicam, a new NSAID: indications for parenteral, dermal and mucosal asministration. Br. J. Rheumatol. suppl, 35: 44-50.
4. Busch, U., Schmid, J., Heinzel, G., Schmaus, H., Baierl, J., Huber, C., Roth, W., 1998. Pharmacokinetics of meloxicam in animals and the relevance to humans. Drug Metab. Dispos. 26: 576-84.
5. Kaplan-Machlis, B., Klostermeyer, B.S., 1999. The cyclooxygenase-2 inhibitors: safety and effectiveness. Ann. Pharmacother. 33: 979-88.
6. Parfitt, K, Martindale: The complete drug reference, 32ed, 1999, Pharmaceutical Press, USA. P52.
7. Gupta, S.K., Bansal, P., Bhardwaj, R.K., Jaiswal, J., Velpandian, T., 2002. Comparison of analgesic and anti-inflammatory activity of meloxicam gel with diclofenac and piroxicam gels in animal models: pharmacokinetic parameters after topical application. Skin Pharmacol. Appl. Skin. Physiol. 15(2): 105-111.
8. Akhter, S.A., Barry, B.W., 1984. Penetration enhancers in human skin-effect of oleic acid and azone on flurbiprofen permeation. J. Pharm. Pharmacol. Suppl, 36, 7p
9. Wotton, P.K., Mollgaard, B., Hadgraft, J., Hoelgarrd, A., 1985. Vehicle effects on topical drug delivery. III. Effect of azone on the cutaneous permeation of metronidazole and propylene glycol. Int. J. Pharm. 24: 19-26.
10. Wu, P.C., Huang, Y.B., Lin, H.H., Tsai, Y.H., 1996. Percutaneous absorption of captopril from hydrophilic cellulose gel® through excised rabbit skin and human skin. Int. J. Pharm. 145: 215-220.
11. Lambert, W.J., Higuchi, W.I., Knutson, K., Krill, S.L., 1989. Dose-dependent enhancement effects of azone on skin permeability. Pharm. Res. 6: 798-803.
12. Hosoya, K.I., Shudo, N., Sugibayashi, K., Morimoto, Y., 1987. Effect of azone on the percutaneous absorption of 5-flurouracil from gels in hairless rats. Chem. Pharm. Bull. 35: 726-733.
13. Ashton, P., Walters, K.A., Brain, K.R., Hadgraft, J., 1992. Surfactant effects in percutaneous absorption I. effects on the Transdermal flux of methyl nicotinate. Int. J. Pharm. 87: 261-264.
14. Williams, A.C., Barry, B.W., 1991. Terpenes and the lipid-protein partitioning theory of skin penetration enhancement. Pharm. Res. 8: 17-24.
15. Kabayashi, D., Matsuzawa, T., Sugibayashi, K., Morimoto, Y., Kimura, M., 1994. Analysis of the combined effect of 1-menthol and ethanol as skin permeation enhancers bases on a two-layer skin model. Pharm. Res. 11: 96-102.
16. Morimoto, Y., Sugibayashi, K., Kobayashi, D., Shoji, H., Yamazaki, J., Kimura, M., 1993. A new enhancer-coenhancer system to increase skin permeation of morphine hydrochloride in vitro. Int. J. Pharm. 91: 9-14.
17. Takayama, K., Nagai, T., 1989. Novel computer optimization methodology for pharmaceutical formulations investigated by using sustained-release granules of indomethacin. Chem. Pharm. Bull. 37: 160-167.
18. Singh, S.K., Dodge, J., Durrani, M.J., Khan, M., 1995. Factorial design in the feasibility of producing Microcel MC 101 pellets by extrusion spheronization. Int. J. Pharm. 115: 53-60.
19. Wu, P.C., Obata, Y., Fujikawa, M., Li, C.J., Higashiyama, K., Takayama, K., 2001. Simultaneous optimization based on artificial neural networks in ketoprofen hydrol formula containing o-ethyl-3-butylcyclo-hexanol as percutaneous absorption enhancer. J. Pharm. Sci. 90: 1004-1014.
20. Huang Y.B., Tsai Y.H., Yang W.C., Chang J.S., Wu P.C., Takayama K., 2004. Once-daily propranolol extended-release tablet dosage form: formulation design and in vitro/in vivo investigation. Eur. J. Pharm. Biopharm. 58: 607-614.
21. Fang, K.T., 1980. Uniform design-application of number theory method in experimental design. Acta Math. Appl. Sinica 3: 363-372.